NVS – novartis ag (US:NASDAQ)

News

Novartis (NYSE:NVS) had its "buy (b)" rating reaffirmed by analysts at Weiss Ratings.
Novartis (NYSE:NVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Janux dives as gaps in prostate cancer study data worry investors [Yahoo! Finance Canada]
Progress In Fight Against Malaria, As New Treatment Shows Promise [Forbes]
Novartis (NYSE:NVS) was upgraded by analysts at Wall Street Zen from
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com